Abstract
Nanotechnology is playing major role in modern therapeutics for effective delivery of drugs to the troublesome target sites. Human eye presents various physiological and anatomical constraints limiting the absorption of therapeutic agent delivered on its surface by conventional ophthalmic dosage forms. Dosage form variables- like particle size, charge on drug particles, elasticity, bioadhesion and corneal surface retention can affect the absorption of the therapeutic element for ocular purposes. Various nanotechnology based systems have been developed for improving ocular therapeutics and increasing market demand has directed efforts for exploring commercial viability of nanotechnology based ocular systems. The nano-ocular therapeutic systems have been classified on the basis of their structures, properties and functionalities. The present review compiles elaborated information on the nano-ocular systems, their utilization, development considerations, intellectual and market aspects and the future prospects for ocular therapy.
Keywords: Nano-ocular systems, vesicular systems, colloidal systems, micelles, dendrimers, nanocomposites, carbon nanotubes, quantum dots
Micro and Nanosystems
Title:Viability of Nanotechnology in Ocular Therapeutics
Volume: 4 Issue: 2
Author(s): Mukesh K. Pathak, Rishabh Srivastava, Gulshan Chhabra and Kamla Pathak
Affiliation:
Keywords: Nano-ocular systems, vesicular systems, colloidal systems, micelles, dendrimers, nanocomposites, carbon nanotubes, quantum dots
Abstract: Nanotechnology is playing major role in modern therapeutics for effective delivery of drugs to the troublesome target sites. Human eye presents various physiological and anatomical constraints limiting the absorption of therapeutic agent delivered on its surface by conventional ophthalmic dosage forms. Dosage form variables- like particle size, charge on drug particles, elasticity, bioadhesion and corneal surface retention can affect the absorption of the therapeutic element for ocular purposes. Various nanotechnology based systems have been developed for improving ocular therapeutics and increasing market demand has directed efforts for exploring commercial viability of nanotechnology based ocular systems. The nano-ocular therapeutic systems have been classified on the basis of their structures, properties and functionalities. The present review compiles elaborated information on the nano-ocular systems, their utilization, development considerations, intellectual and market aspects and the future prospects for ocular therapy.
Export Options
About this article
Cite this article as:
Pathak Mukesh K., Srivastava Rishabh, Chhabra Gulshan and Pathak Kamla, Viability of Nanotechnology in Ocular Therapeutics, Micro and Nanosystems 2012; 4 (2) . https://dx.doi.org/10.2174/1876402911204020128
DOI https://dx.doi.org/10.2174/1876402911204020128 |
Print ISSN 1876-4029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-4037 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Discovering Tumor Suppressor Genes Through Genome-Wide Copy Number Analysis
Current Genomics Current Molecular Understanding and Future Treatment Strategies for Pathologic Ocular Neovascularization
Current Molecular Medicine Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Ex vivo and In vivo Evaluation of Chitosan Coated Nanostructured Lipid Carriers for Ocular Delivery of Acyclovir
Current Drug Delivery <i>In-Silico</i> Validation and Fabrication of Matrix Diffusion-Based Polymeric Transdermal Patches for Repurposing Gabapentin Hydrochloride in Neuropathic Pain
CNS & Neurological Disorders - Drug Targets Antiviral Effects of Saffron and its Major Ingredients
Current Drug Delivery Multifunctional Lipoic Acid Conjugates
Current Medicinal Chemistry Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications
Recent Patents on Cardiovascular Drug Discovery Metabolism Evolution Based on Network Degrees of Orthologous Enzymes
Current Topics in Medicinal Chemistry Past, Present and Future Therapeutics for Cerebellar Ataxias
Current Neuropharmacology Nanoparticles in the Pharmaceutical Industry and the Use of Supercritical Fluid Technologies for Nanoparticle Production
Current Drug Delivery An Overview on Chemistry and Biological Importance of Pyrrolidinone
Current Organic Synthesis Hsp90 Affecting Chromatin Remodeling Might Explain Transgenerational Epigenetic Inheritance in Drosophila
Current Genomics Dietary Approaches and Alternative Therapies for Rheumatoid Arthritis
Current Nutrition & Food Science Novel, Unifying Phagomimetic Mechanism of Vancomycin Therapeutic Action and Toxicity: Polyphenol, Electron Transfer and Reactive Oxygen Species
Anti-Infective Agents in Medicinal Chemistry Specific Immune Intervention with Monoclonal Antibodies for the Treatment of Multiple Sclerosis
Current Medicinal Chemistry Iontophoresis: Drug Delivery System by Applying an Electrical Potential Across the Skin
Drug Delivery Letters Emerging Treatment Strategies and Potential Therapeutic Targets in Primary Sjogrens Syndrome
Inflammation & Allergy - Drug Targets (Discontinued) Involvement of Lanthanides in the Free Radicals Homeostasis
Current Topics in Medicinal Chemistry Destroying RNA as a Therapeutic Approach
Current Medicinal Chemistry